However, the CRISPR Cancer Dependency Map (DepMap) found that targeting of CTPS2 only mildly affects proliferation of a broad range of cancer cells, including B-cell lymphomas (see Fig. S3A). The gene discussed is CTPS2; the disease is B-cell non-Hodgkin lymphoma.